Trial Assessing Long Term USe of PCSK9 Inhibition in Subjects With Genetic LDL Disorders

Clinical trial NCT01624142 · COMPLETED

Trial details

NCT number: NCT01624142
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Severe Familial Hypercholesterolemia

Start date: 2012-06-01
Primary completion: 2018-05-11
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.